A synergistic antimicrobial composition containing flumetsulam and thiabendazole.

Patent
   8609590
Priority
Nov 09 2010
Filed
Nov 04 2011
Issued
Dec 17 2013
Expiry
Nov 04 2031
Assg.orig
Entity
Large
0
6
EXPIRED
1. A synergistic antimicrobial composition comprising:
(a) flumetsulam; and (b) thiabendazole; wherein a weight ratio of flumetsulam to thiabendazole is from 6:1 to 1:10.
2. The composition of claim 1 which is a building material.
3. The composition of claim 2 in which the building material is a paint, coating, polymer, plastic, synthetic or natural rubber, paper product, fiberglass sheet, insulation, exterior insulating finishing system, roofing or flooring felt, building plaster, wood product or wood-plastic composite.

This invention relates to combinations of biocides, the combinations having greater activity than would be observed for the individual antimicrobial compounds.

Use of combinations of at least two antimicrobial compounds can broaden potential markets, reduce use concentrations and costs, and reduce waste. In some cases, commercial antimicrobial compounds cannot provide effective control of microorganisms, even at high use concentrations, due to weak activity against certain types of microorganisms, e.g., those resistant to some antimicrobial compounds. Combinations of different antimicrobial compounds are sometimes used to provide overall control of microorganisms in a particular end use environment. For example, U.S. Pat. No. 5,591,760 discloses a combination of 3-iodo-2-propynyl-butylcarbamate (IPBC) and 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOIT), but this reference does not suggest any of the combinations claimed herein. Moreover, there is a need for additional combinations of antimicrobial compounds having enhanced activity against various strains of microorganisms to provide effective control of the microorganisms, especially in dry film coatings. The problem addressed by this invention is to provide such additional combinations of antimicrobial compounds.

The present invention is directed to a synergistic antimicrobial composition comprising: (a) flumetsulam; and (b) thiabendazole (TBZ); wherein a weight ratio of flumetsulam to thiabendazole is from 8:1 to 1:15.

As used herein, the following terms have the designated definitions, unless the context clearly indicates otherwise. Flumetsulam is N-(2,6-difluorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide. Diclosulam is N-(2,6-dichlorophenyl)-5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide. The term “antimicrobial compound” refers to a compound capable of inhibiting the growth of or controlling the growth of microorganisms; antimicrobial compounds include bactericides, bacteristats, fungicides, fungistats, algaecides and algistats, depending on the dose level applied, system conditions and the level of microbial control desired. The term “microorganism” includes, for example, fungi (such as yeast and mold), bacteria and algae. The following abbreviations are used throughout the specification: ppm=parts per million by weight (weight/weight), mL=milliliter, ATCC=American Type Culture Collection, and MIC=minimum inhibitory concentration. Unless otherwise specified, temperatures are in degrees centigrade (° C.), and references to percentages are by weight (wt %). Percentages of antimicrobial compounds in the composition of this invention are based on the total weight of active ingredients in the composition, i.e., the antimicrobial compounds themselves, exclusive of any amounts of solvents, carriers, dispersants, stabilizers or other materials which may be present.

Preferably, a weight ratio of flumetsulam to ZPT is from 8:1 to 1:12, preferably from 8:1 to 1:10, preferably from 7:1 to 1:12; preferably from 7:1 to 1:10; preferably from 6:1 to 1:12; preferably from 6:1 to 1:10; preferably from 6:1 to 1:8.

The antimicrobial compositions described above may contain other biocides. Typically, the antimicrobial compositions are used to inhibit growth of algae and/or fungi.

Preferably, the antimicrobial combinations of this invention are incorporated into liquid compositions, especially dispersions of polymers in aqueous media. The biocide combinations are particularly useful in preservation of building materials, e.g., adhesives, caulk, joint compound, sealant, wallboard, etc), paints, coatings, polymers, plastics, synthetic and natural rubber, paper products, fiberglass sheets, insulation, exterior insulating finishing systems, roofing and flooring felts, building plasters, wood products and wood-plastic composites. Preferably, the antimicrobial compositions are latex paints or other liquid coating compositions containing the biocide combinations disclosed herein. The biocide combinations are useful for preservation of the dry film coating resulting after application of a paint or other liquid coating composition. Preferably, the antimicrobial composition is an acrylic latex paint comprising one or more of the biocide combinations disclosed herein, or the dry film coating resulting from application of the paint to a surface.

Typically, the amount of the biocide combinations of the present invention to control the growth of microorganisms is from 100 ppm to 10,000 ppm active ingredient. Preferably, the active ingredients of the composition are present in an amount of at least 300 ppm, preferably at least 500 ppm, preferably at least 600 ppm, preferably at least 700 ppm. Preferably, the active ingredients of the composition are present in an amount of no more than 8,000 ppm, preferably no more than 6,000 ppm, preferably no more than 5,000 ppm, preferably no more than 4,000 ppm, preferably no more than 3,000 ppm, preferably no more than 2500 ppm, preferably no more than 2,000 ppm, preferably no more than 1,800 ppm, preferably no more than 1,600 ppm. Concentrations mentioned above are in a liquid composition containing the biocide combinations; biocide levels in the dry film coating will be higher.

The present invention also encompasses a method for preventing microbial growth in building materials, especially in dry film coatings, by incorporating any of the claimed biocide combinations into the materials.

Sample preparation: A single or blend of biocides was post added into white acrylic latex paint free of biocides to give a maximum total active ingredient/s concentration tested. This paint was then diluted with a biocide free acrylic latex paint to give targeted concentrations for the testing. Depending on the type of biocide blends tested, the total biocides concentrations varies from 200 to 5000 ppm. After biocides addition or dilution, each sample was hand mixed for at least a minute until uniformity is achieved. Each of the paint samples as well as a control sample (containing no biocide) were used to prepare films on black plastic-vinyl chloride/acetate copolymer panels (LENETA, Mahwah, N.J.) using a 3 mil (0.0762 mm) bird bar applicator. The panels were thoroughly dried for at least 2 days avoiding direct exposure to sunlight. Square discs (0.5 inch; 1.27 cm2) were cut out from each panel and were used as the substrate for fungal and algal efficacy tests. This sample size allowed for an agar border when the sample disc was placed into the well of the test plate. Each sample was tested in duplicate

Test Conditions:

The appropriate media (BOLD'S 3N for Chlorophytes, BG-11 for Cyanobacteria, and PDA for fungi) were used to support microbial growth. The test plates were maintained at room temp (25° C.-26° C.), in a cycled light-dark environment, for four weeks for algae. Plates for fungal challenge tests were maintained at 30 C for four weeks. At the end of the incubation period the samples were scored for percent area covered by visible microbial growth.

Algal Inoculum

Medium for
Organisms abbreviation Type testing
Gloeocapsa sp. Gs ATCC 29159 Unicellular, BG-11
Colonial
Cyanobacteria
Oscillatoria sp. Os ATCC 29135 Filamentous BG-11
Cyanobacteria
Nostoc commune Nc CCAP 1453/29 Unicellular, Bold
Cenobial
Chlorophyte
Trentepohlia aurea + Ta + To UTEX LB 429 + Filamentous Bold
Trentepohlia odorata CCAP 483/4 Chlorophyte
Chlorella sp. UTEX + Cs + Ck ATCC 30582 + Unicellular Bold
Chlorella kessleri ATCC 11468 Chlorophyte
Calothrix parientina Cp UTEX LB 1952 Filamentous Bold
Cyanobacteria

Fungal Inoculum

Medium for
Organisms abbreviation ATCC# Growth and Testing
Aspergillus niger An 9642 PDA
Penicillium funiculosum Pf 11797 PDA
Cladosporium herbarum Ch 11281 PDA
Aureobasidium pullulans Ap 9348 PDA
Trichoderma viride Tv 32630 PDA
Alternaria alternata Aa 20084 PDA

Algal Efficacy Testing
Modified ASTM 5589

ASTM 5589 is a standard accelerated test method for determining resistance of various coatings (including paints) to algal defacement. To accommodate for high-throughput screening, this method was scaled down from petri plates to 6-well plates. A single coupon was placed with a pair of sterile forceps at the center of the agar plug (on top) with the painted surface facing upwards. Algal inoculums were prepared by mixing equal concentrations (1×106 cfu/ml) and equal volumes (depending on number of samples to be inoculated) of like growing organisms.

In Flumetsulam+various IT synergy study, three pool of mixed algae were prepared as the test inoculum, Gloeocapsa sp. and Oscillatoria sp. a mix of cyanobacteria grown on BG-11 media; Chlorella sp., Chlorella kessleri, and Nostoc commune are unicellular chlorphytes that were mixed and grown on Bold media; Trentepohlia aurea, Tretepohlia odorata, and Calotrix parientina are filamentous algae that were mixed and grown on Bold media.

In Diclosulam+various IT synergy study, only two pools of mixed algae were prepared; Gloeocapsa sp. and Oscillatoria sp. grown on BG-11 media and Chlorella sp., Chlorella kessleri, Nostoc commune, Trentepohlia aurea, Tretepohlia odorata, and Calotrix parientina grown on Bold media

Each well that contains a tested coupon was inoculated with 400 μl of organism mixture (1×106 cfu/ml) making sure that the whole surface (paint film as well as the agar surrounding it) was evenly covered. The plates were incubated at room temp (25° C.-26° C.) with cyclic exposure to light (OTT-Lite model # OTL4012P, 40 Watt, 26 KLumen) and dark phases, for a period of four weeks. The total area covered was evaluated at the end of each week according to percent area covered in 5% increments.

Fungal Efficacy Testing—Modified ASTM 5590

ASTM 5590 is a standard accelerated test method for determining resistance of various coatings (including paints) to fungal defacement. To accommodate for high-throughput screening, this method was scaled down from petri plates to 6-well plates. To set up the test, an agar plug was placed at the bottom of each well of the sterile 6-well plate. A single coupon was placed with a pair of sterile forceps at the center of the agar plug (on top) with the painted surface facing upwards. Fungal inoculums were prepared by mixing equal concentrations (1×106 cfu/ml) and equal volumes (depending on number of samples to be tested) of like growing organisms. For Flumetsulam+various IT synergy study, three pools of mixed fungi were prepared as the test inoculum. Cladosporium herbarum was mixed with Aureobasidium pullulans; Aspergillus niger was mixed with Penicillium funiculosum and Alternaria alternata was mixed with Trichoderma viride. For Diclosulam+various IT synergy study, all above fungi were mixed as a single pool. Each well was inoculated with 400 μl of organism mixture (1×106 cfu/ml) making sure that the whole surface (paint film as well as the agar surrounding it) was evenly covered. The plates were incubated at 30° C. in presence of moisture, for a period of four weeks. The total percent area covered was evaluated and recorded at the end of each week after the 2nd week and recorded in increments of 5%.

Synergy Index Calculation

Synergy Index (SI)

The SI is calculated based on F. C. Kull et. Al. method (Applied Microbiology, Vol. 9 (1961). In this study, SI was calculated based on the following formula with the minimum inhibitory concentration chosen based on the percent inhibitory exhibited by the individual biocide against each microorganisms tested.
SI=Qa/QA+Qb/QB

Flumetsulam: TBZ Synergy study
Cp + Cs +
AaTv AnPf ApCh To + Ta Ck + Nc Gs + Os
1Flumet:
1TBZ
Total conc, 1000 1000 1000 4000 4000 2000
ppm
% inhibition 100 100 100 40 100 90
SI <0.94 1.1 0.9 1.7 1.6 0.7
1Flumet:
3TBZ
Total conc, 1000 1000 1000 4000 3000 2000
ppm
% inhibition 100.0 100 100 90 100 90
SI <1.27 1.3 1.3 1.4 1.2 0.6
1Flumet:
5TBZ
Total conc, 900 900 900 3600 3600 900
ppm
% inhibition 100 100 100 50 50 100
SI <1.24 1.3 1.2 1.1 1.4 0.3
1Flumet:
10TBZ
Total conc, 962.5 962.5 962.5 3850 3850 2888
ppm
% inhibition 100 90 100 40 40 90
SI <1.43 1.5 1.4 1.1 1.5 0.8
6Flumet:
1TBZ
Total conc, 875 875 1750 3500 3500 875
ppm
% inhibition 100 100 100 40 40 90
SI <0.41 0.7 0.8 1.9 1.3 0.3
4Flumet:
1TBZ
Total conc, 937.5 937.5 937.5 2813 3750 1875
ppm
% inhibition 100 90 100 80 70 90
SI <0.51 0.7 0.5 1.4 1.4 0.7
2Flumet:
1TBZ
Total conc, 937.5 37.5 3750 2813 3750 2813
ppm
% inhibition 100 95 100 90 70 100
SI <0.68 0.9 2.7 1.3 1.5 1.0
Flumetsulam
Total conc, 3500 1750 3500 1750 2625 2625
ppm
% inhibition 0 90 50 75 100 90
TBZ
Total conc, 625 625 625 3750 2500 3750
ppm
% inhibition 100 100 100 90 100 85
Note:
If any of the active with maximum concentration tested did not exhibit some inhibition, this maximum concentration is used to calculate the estimated SI and a sign of less than (<) is included to take into account that higher concentration of the active is needed to achieve the targeted inhibition
NE = no end point at the concentration tested that will meet the percent inhibition criteria set in each SI calculation

Synergy study of Diclosulam and TBZ
Aa + Tv + An + Cp + To + Ta +
Ratios Pf + Ap + Ch Cs + Ck + Nc Gs + Os
1Diclosulam: 1 TBZ
Total conc, ppm 1500 3000 3000
% inhibition 60 100 100
SI 1.4 2.1 2.9
3Dicolosulam: 1 TBZ
Total conc, ppm 2250 3000 750
% inhibition 60 50 90
SI 1.4 1.9 1.8
5Diclosulam: 1 TBZ
Total conc, ppm 300 3000 3000
% inhibition 50 80 100
SI 1.5 1.8 4.1
10Diclosulam: 1 TBZ
Total conc, ppm 2750 2750 687.5
% inhibition 50 80 95
SI 1.1 1.6 1.9
1Diclosulam: 10 TBZ
Total conc, ppm 3000 3300 825
% inhibition 50 80 90
SI 4.9 2.6 1.3
1Diclosulam: 6 TBZ
Total conc, ppm 2800 2800 2800
% inhibition 50 95 100
SI 4.0 2.1 1.7
1Diclosulam: 4 TBZ
Total conc, ppm 3250 3250 812.5
% inhibition 50 90 100
SI 4.3 2.5 1.4
1Diclosulam: 2 TBZ
Total conc, ppm 3000 3000 750
% inhibition 60 75 100
SI 3.5 2.2 1.5
Diclosulam
Total conc, ppm 3500 1750 875
% inhibition 0 100 90
TBZ
Total conc, ppm 625 1250 1250
% inhibition 60 100 85

Sianawati, Emerentiana

Patent Priority Assignee Title
Patent Priority Assignee Title
5591760, Nov 02 1989 Rohm and Haas Company Synergistic microbicidal combinations containing 4,5-dichloro-2-octyl-3-isothiazolone and certain commercial biocides
20040198713,
20070104751,
20070224250,
EP1468608,
WO2006089654,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 07 2011SIANAWATI, EMERENTIANADow Global Technologies LLCASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0316500379 pdf
Nov 04 2011Dow Global Technologies LLC(assignment on the face of the patent)
Date Maintenance Fee Events
Jun 01 2017M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Aug 09 2021REM: Maintenance Fee Reminder Mailed.
Jan 24 2022EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Dec 17 20164 years fee payment window open
Jun 17 20176 months grace period start (w surcharge)
Dec 17 2017patent expiry (for year 4)
Dec 17 20192 years to revive unintentionally abandoned end. (for year 4)
Dec 17 20208 years fee payment window open
Jun 17 20216 months grace period start (w surcharge)
Dec 17 2021patent expiry (for year 8)
Dec 17 20232 years to revive unintentionally abandoned end. (for year 8)
Dec 17 202412 years fee payment window open
Jun 17 20256 months grace period start (w surcharge)
Dec 17 2025patent expiry (for year 12)
Dec 17 20272 years to revive unintentionally abandoned end. (for year 12)